跳至主要内容
临床试验/NCT00304980
NCT00304980终止不适用

Comparative Evaluation of the Safety and the Efficacy of Artemether + Lumefantrine (Coartem™) vs. Sulfadoxine + Pyrimethamine (SP) in Both HIV+ and HIV- Adults With Uncomplicated P. Falciparum Malaria in Zambia

Institute of Tropical Medicine, Belgium1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2003年3月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3,000
试验地点
1
主要终点
PCR corrected clinical and parasitological outcome at day 45

研究概览

简要总结

The purpose of this study is to determine the safety and efficacy of sulfadoxine-pyrimethamine (SP) versus artemether-lumefantrine (Coartem) when administered to HIV+ and HIV- patients with uncomplicated P. falciparum malaria. Patients will be randomised to one of the 2 treatment and followed up (until day 14 actively) for 45 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Man and non-pregnant women aged between 15 and
  • P.falciparum mono-infection of at least 1,000 parasites/µl.
  • Body temperature ≥ 37.5°C at the moment of enrolment or history of fever in the preceding 48 hrs.
  • Consent from patient obtained.

排除标准

  • Pregnancy.
  • Severe P. falciparum malaria .
  • Documented intake of SP or Coartem two weeks or less prior recruitment.
  • Other cause(s) of fever.
  • Evidence of underlying chronic diseases (cardiac, renal, hepatic, malnutrition).
  • History of allergy to study drug, or known allergy to other Sulphur drugs such as co-trimoxazol.

结局指标

主要结局

PCR corrected clinical and parasitological outcome at day 45

次要结局

  • Tolerability
  • Clinical recovery

研究者

发起方
Institute of Tropical Medicine, Belgium
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Comparative Evaluation of the Safety and the... | 临床试验